节点文献

厄贝沙坦联合胺碘酮在心力衰竭合并心律失常患者中的治疗效果及对心功能的影响

Therapeutic effect and influence on heart function of irbesartan combined with amiodarone in patients with heart failure complicated by arrhythmia

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 林青刘宝宏吴献豪李治民张烨蓓

【Author】 LIN Qing;LIU Bao-hong;WU Xian-hao;LI Zhi-min;ZHANG Ye-bei;Department of Cardiovascular Diseases, Tong Ren Hospital,Shanghai;

【机构】 上海市同仁医院心血管内科上海市同仁医院急诊科上海市同仁医院检验科上海市同仁医院心功能室

【摘要】 目的分析厄贝沙坦联合胺碘酮在心力衰竭(心衰)合并心律失常患者中的治疗效果及对心功能的影响。方法选取2014年5月~2016年10月于上海市同仁医院接受治疗的心衰合并心律失常患者90例,男性39例,女性51例。随机分成观察组与对照组,各45例。对照组为常规治疗方式加服胺碘酮;观察组在对照组的基础上加服厄贝沙坦,疗程为6个月。治疗后评价两组疗效,并检测心电图,记录心率和QT离散度。在治疗前和治疗后超声心动图测定左室收缩末期内径(LVESD)、每搏心输出量(SV)、左室舒张末期内径(LVEDD)和左室射血分数(LVEF)。结果观察组总有效率为97.78%,对照组为80.00%,观察组明显高于对照组,差异有统计学意义(P<0.05)。与治疗前比较,两组治疗后SV、LVEF、LVESD和LVEDD均明显改善,差异有统计学意义(P均<0.05)。与对照组治疗后比较,观察组LVESD和LVEDD降低,而SV及LVEF升高,差异有统计学意义(P均<0.05)。经过6个月治疗,观察组患者QT离散度和心率均优于对照组,差异有统计学意义(P均<0.05)。结论厄贝沙坦联合胺碘酮治疗心衰合并心律失常患者效果显著,并且改善患者的心功能,值得在临床中推广使用。

【Abstract】 Objective To analyze the therapeutic effect and influence on heart function of irbesartan combined with amiodarone in patients with heart failure complicated by arrhythmia. Methods The patients(n=90, male 39 and female 51) were chosen from the Tong Ren Hospital of Shanghai City from May 2014 to Oct. 2016, and divided randomly into observation group and control group(each n=45). The control group was given routine therapy and amiodarone, and observation group was additionally given irbesartan for 6 months. The curative effect was reviewed, electrocardiogram(ECG) was detected, and heart rate(HR) and QT interval dispersion(QTd) were recorded in 2 groups after treatment. The left ventricular end-systolic diameter(LVESD), stroke volume(SV), left ventricular end-diastolic inner diameter(LVEDD) and left ventricular ejection fraction(LVEF) were detected by using echocardiogram before and after treatment. Results The total effective rate was 97.78% in observation group and 80.00% in control group(P<0.05). SV, LVEF, LVESD and LVEDD were significantly improved in 2 groups after treatment(all P<0.05). LVESD and LVEDD decreased and SV and LVEF increased in observation group compared with control group after treatment(all P<0.05). After treatment for 6 months, QTd and HR were all superior in observation group to those in control group(all P<0.05). Conclusion Irbesartan combined with amiodarone has significant efficacy and can improve heart function in patients with heart failure complicated by arrhythmia, which is well worth clinical application.

【关键词】 厄贝沙坦心力衰竭心率失常碘酮片
【Key words】 IrbesartanHeart failureArrhythmiaAmiodarone tablets
  • 【文献出处】 中国循证心血管医学杂志 ,Chinese Journal of Evidence-Based Cardiovascular Medicine , 编辑部邮箱 ,2017年06期
  • 【分类号】R541
  • 【被引频次】66
  • 【下载频次】77
节点文献中: 

本文链接的文献网络图示:

本文的引文网络